Marc Nikolaus, Philipp Rausch, Kevin Rostásy, Annikki Bertolini, Ronny Wickström, Jessika Johannsen, Jonas Denecke, Markus Breu, Mareike Schimmel, Katharina Diepold, Martin Haeusler, Annegret Quade, Andrea Berger, Hendrik Rosewich, Claudia Steen, Katja von Au, Mona Dreesmann, Carsten Finke, Frederik Bartels, Angela M Kaindl, Markus Schuelke, Ellen Knierim
BACKGROUND AND OBJECTIVES: Anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) is the most common form of autoimmune encephalitis in children and adults. Although our understanding of the disease mechanisms has progressed, little is known about estimating patient outcomes. Therefore, the NEOS (anti- N MDAR E ncephalitis O ne-Year Functional S tatus) score was introduced as a tool to predict disease progression in NMDARE. Developed in a mixed-age cohort, it currently remains unclear whether NEOS can be optimized for pediatric NMDARE...
May 2023: Neurology® Neuroimmunology & Neuroinflammation